NODUS THERAPEUTICS Trademark

Trademark Overview

On Thursday, December 10, 2015, a trademark application was filed for NODUS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NODUS THERAPEUTICS trademark a serial number of 86845276. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 5, 2024. This trademark is owned by NODUS THERAPEUTICS, INC.. The NODUS THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and pharmaceutical research and development relating to oncology; medical and scientific research in the field of oncology; custom design and development of oncology drugs, antibodies, and proteins
nodus therapeutics

General Information

Serial Number86845276
Word MarkNODUS THERAPEUTICS
Filing DateThursday, December 10, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 5, 2024
Registration Number5297091
Registration DateTuesday, September 26, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2016

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical and pharmaceutical research and development relating to oncology; medical and scientific research in the field of oncology; custom design and development of oncology drugs, antibodies, and proteins

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2024
Primary Code042
First Use Anywhere DateTuesday, May 16, 2017
First Use In Commerce DateTuesday, May 16, 2017

Trademark Owner History

Party NameXCELLA BIOSCIENCES
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025
Party NameNODUS THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameNODUS THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameNODUS THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Wednesday, April 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2016PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, December 14, 2015NEW APPLICATION ENTERED
Tuesday, December 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 28, 2016ASSIGNED TO EXAMINER
Tuesday, March 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2016SOU EXTENSION 1 FILED
Wednesday, December 21, 2016SOU EXTENSION 1 GRANTED
Saturday, June 24, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 21, 2016SOU TEAS EXTENSION RECEIVED
Friday, December 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, May 24, 2017USE AMENDMENT FILED
Wednesday, June 21, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 22, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 26, 2017SU - NON-FINAL ACTION - WRITTEN
Monday, June 26, 2017NON-FINAL ACTION E-MAILED
Monday, June 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 3, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, July 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 3, 2017ASSIGNED TO LIE
Saturday, August 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 21, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 26, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, July 10, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, September 26, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 5, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

therapeutics nodus oncology medical development research drugs proteins design antibodies scientific pharmaceutical